We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Ubiquitin Ligase Protects Against Autoimmune Disease

By Biotechdaily staff writers
Posted on 12 Sep 2004
Researchers have found that the ubiquitin ligase Cbl-b plays a critical role in preventing the development of arthritis and other autoimmune diseases.

Ubiquitin (Ub) is a small protein composed of 76 amino acids. More...
This protein is found in all cells of eukaryotic organisms. Ubiquitin is highly conserved, meaning that the amino acid sequence does not differ much when very different organisms are compared. For example, there are only three differences in the sequence when Ub from yeast is compared to human Ub. This strong sequence conservation suggests that the vast majority of amino acids that make up Ub are essential, as apparently any mutations that have occurred over evolutionary history have been removed by natural selection.

Ubiquitin becomes attached covalently to certain residues of other proteins. The attachment of a chain of ubiquitins tags a protein for intracellular proteolytic destruction. Ubiquitin ligases are a class of enzymes that determines the substrate protein to which a ubiquitin will be linked and that binds the ubiquitin to this protein. Many ubiquitin ligases are multi-subunit proteins.

In the current study, investigators from the La Jolla Institute for Allergy and Immunology (San Diego, CA, USA) and the Institute for Molecular Biotechnology of the Austrian Academy of Sciences (Vienna, Austria) worked with mice genetically engineered to lack the gene for Cbl-b. These mice as well as a normal control group were injected with substances known to induce arthritis. Results reported in the August 2004 issue of Immunity revealed that while the normal mice did not respond to the injection, the mice lacking Cbl-b developed severe symptoms of arthritis.
"We concluded that the Cbl-b molecule was affecting the T cell's immune response, giving the immune system of the normal mice the ability to ‘tolerate' the arthritis antigens,” explained contributing author Dr. Yun-Cai Liu, a researcher at the La Jolla Institute for Allergy and Immunology. "The mice without the Cbl-b molecule could not tolerate these substances and their T cells began attacking their own tissues, leading to the development of the autoimmune disease.”

Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Parainfluenza Virus Test
PARAINFLUENZA ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.